Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation

被引:77
作者
Farrell, Michelle E. [1 ]
Jiang, Shu [1 ,3 ,4 ]
Schultz, Aaron P. [1 ]
Properzi, Michael J. [1 ]
Price, Julie C. [2 ]
Becker, J. Alex [2 ]
Jacobs, Heidi I. L. [2 ,5 ]
Hanseeuw, Bernard J. [2 ,6 ]
Rentz, Dorene M. [1 ,7 ]
Villemagne, Victor L. [8 ]
Papp, Kathryn, V [1 ,7 ]
Mormino, Elizabeth C. [9 ]
Betensky, Rebecca A. [1 ,3 ,10 ]
Johnson, Keith A. [1 ,2 ]
Sperling, Reisa A. [1 ,7 ]
Buckley, Rachel F. [1 ,7 ,11 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[5] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Med & Life Sci,Fac Hlth, Maastricht, Netherlands
[6] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium
[7] Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA
[8] Austin Hlth, Dept Mol Imaging & Therapy, Melbourne, Vic, Australia
[9] Stanford Univ, Dept Neurosci, Palo Alto, CA 94304 USA
[10] NYU, Sch Global Publ Hlth, Dept Biostat, New York, NY 10003 USA
[11] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia
基金
加拿大健康研究院;
关键词
ALZHEIMERS-DISEASE; APOE EPSILON-4; BETA; NEURODEGENERATION; ASSOCIATION; BIOMARKERS; DEPOSITION; PROGRESS; CORE;
D O I
10.1212/WNL.0000000000011214
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction As clinical trials move toward earlier intervention, we sought to redefine the beta-amyloid (A beta)-PET threshold based on the lowest point in a baseline distribution that robustly predicts future A beta accumulation and cognitive decline in 3 independent samples of clinically normal individuals. Methods Sequential A beta cutoffs were tested to identify the lowest cutoff associated with future change in cognition (Preclinical Alzheimer Cognitive Composite [PACC]) and A beta-PET in clinically normal participants from the Harvard Aging Brain Study (n = 342), Australian Imaging, Biomarker and Lifestyle study of aging (n = 157), and Alzheimer's Disease Neuroimaging Initiative (n = 356). Results Within samples, cutoffs derived from future A beta-PET accumulation and PACC decline converged on the same inflection point, beyond which trajectories diverged from normal. Across samples, optimal cutoffs fell within a short range (Centiloid 15-18.5). Discussion These optimized thresholds can help to inform future research and clinical trials targeting early A beta. Threshold convergence raises the possibility of contemporaneous early changes in A beta and cognition.
引用
收藏
页码:E619 / E631
页数:13
相关论文
共 52 条
[11]   Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults [J].
Farrell, Michelle E. ;
Chen, Xi ;
Rundle, Melissa M. ;
Chan, Micaela Y. ;
Wig, Gagan S. ;
Park, Denise C. .
NEUROLOGY, 2018, 91 (19) :E1809-E1821
[12]   Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults Evidence for a Dose-Response Relationship [J].
Farrell, Michelle E. ;
Kennedy, Kristen M. ;
Rodrigue, Karen M. ;
Wig, Gagan ;
Bischof, Gerard N. ;
Rieck, Jennifer R. ;
Chen, Xi ;
Festini, Sara B. ;
Devous, Michael D., Sr. ;
Park, Denise C. .
JAMA NEUROLOGY, 2017, 74 (07) :830-838
[13]   In vivo staging of regional amyloid deposition [J].
Grothe, Michel J. ;
Barthel, Henryk ;
Sepulcre, Jorge ;
Dyrba, Martin ;
Sabri, Osama ;
Teipel, Stefan J. .
NEUROLOGY, 2017, 89 (20) :2031-2038
[14]   Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study [J].
Hanseeuw, Bernard J. ;
Betensky, Rebecca A. ;
Jacobs, Heidi I. L. ;
Schultz, Aaron P. ;
Sepulcre, Jorge ;
Becker, J. Alex ;
Cosio, Danielle M. Orozco ;
Farrell, Michelle ;
Quiroz, Yakeel T. ;
Mormino, Elizabeth C. ;
Buckley, Rachel F. ;
Papp, Kathryn V. ;
Amariglio, Rebecca A. ;
Dewachter, Ilse ;
Ivanoiu, Adrian ;
Huijbers, Willem ;
Hedden, Trey ;
Marshall, Gad A. ;
Chhatwal, Jasmeer P. ;
Rentz, Dorene M. ;
Sperling, Reisa A. ;
Johnson, Keith .
JAMA NEUROLOGY, 2019, 76 (08) :915-924
[15]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356
[16]   Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease [J].
Ikonomovic, Milos D. ;
Klunk, William E. ;
Abrahamson, Eric E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott ;
Bi, Wenzhu ;
Paljug, William R. ;
Debnath, Manik L. ;
Hope, Caroline E. ;
Isanski, Barbara A. ;
Hamilton, Ronald L. ;
DeKosky, Steven T. .
BRAIN, 2008, 131 :1630-1645
[17]   Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention [J].
Insel, Philip S. ;
Mormino, Elizabeth C. ;
Aisen, Paul S. ;
Thompson, Wesley K. ;
Donohue, Michael C. .
BRAIN COMMUNICATIONS, 2020, 2 (01)
[18]   A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers [J].
Jack, Clifford R., Jr. ;
Bennett, David A. ;
Blennow, Kaj ;
Carrillo, Maria C. ;
Feldman, Howard H. ;
Frisoni, Giovanni B. ;
Hampel, Harald ;
Jagust, William J. ;
Johnson, Keith A. ;
Knopman, David S. ;
Petersen, Ronald C. ;
Scheltens, Philip ;
Sperling, Reisa A. ;
Dubois, Bruno .
NEUROLOGY, 2016, 87 (05) :539-547
[19]   NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease [J].
Jack, Clifford R., Jr. ;
Bennett, David A. ;
Blennow, Kaj ;
Carrillo, Maria C. ;
Dunn, Billy ;
Haeberlein, Samantha Budd ;
Holtzman, David M. ;
Jagust, William ;
Jessen, Frank ;
Karlawish, Jason ;
Liu, Enchi ;
Luis Molinuevo, Jose ;
Montine, Thomas ;
Phelps, Creighton ;
Rankin, Katherine P. ;
Rowe, Christopher C. ;
Scheltens, Philip ;
Siemers, Eric ;
Snyder, Heather M. ;
Sperling, Reisa ;
Elliott, Cerise ;
Masliah, Eliezer ;
Ryan, Laurie ;
Silverberg, Nina .
ALZHEIMERS & DEMENTIA, 2018, 14 (04) :535-562
[20]   Defining imaging biomarker cut points for brain aging and Alzheimer's disease [J].
Jack, Clifford R., Jr. ;
Wiste, Heather J. ;
Weigand, Stephen D. ;
Therneau, Terry M. ;
Lowe, Val J. ;
Knopman, David S. ;
Gunter, Jeffrey L. ;
Senjem, Matthew L. ;
Jones, David T. ;
Kantarci, Kejal ;
Machulda, Mary M. ;
Mielke, Michelle M. ;
Roberts, Rosebud O. ;
Vemuri, Prashanthi ;
Reyes, Denise A. ;
Petersen, Ronald C. .
ALZHEIMERS & DEMENTIA, 2017, 13 (03) :205-216